Enhanced bafilomycin A1 production in Streptomyces Griseobrunneus via protoplast fusion combined with high-throughput screening
World Journal of Microbiology and Biotechnology · 2025
DOI: 10.1007/s11274-025-04602-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Microbiology and Biotechnology, 2025. Verfasst von Fei Sun und 6 weiteren Autor:innen. Beteiligte Einrichtung: Fujian Key Laboratory of Screening for Novel Microbial Products, Fujian Institute of Microbiology, 25 Jinbu Road, Fuzhou, 350007, P. R. China. Hauptthemen laut MEDLINE: Macrolides, High-Throughput Screening Assays, Streptomyces, Protoplasts. Die Arbeit nennt 44 Literaturangaben. Gefördert von: The Key Technology Research on High-Yield Strain Selection and Fermentation Process of V-ATPase Inhibitor Bafilomycin.
Abstract (Originalsprache)
Bafilomycin A1 (Baf A1), a macrolide antibiotic, has garnered significant attention in medical fields as a specific and reversible V-ATPase inhibitor. To enhance the screening efficiency for high-yield Baf A1 strains of Streptomyces griseobrunneus after mutagenesis, a high-throughput screening model utilizing 48-well deep plates was established, with optimal fermentation conditions being a liquid volume of 3 mL for 4 d at 250 rpm. In this way, a high-yield mutant strain Y98 that produced 892.37 µg/mL Baf A1 was screened through protoplast fusion combined with 48-well deep plate fermentation technology, representing 1.22-fold, 1.42-fold, and 2.77-fold increases compared to AN-125, UV-21, and the original strain FIM-B0711, respectively. Transcriptomic sequencing analysis revealed potential mechanisms underlying the high yield of Baf A1 in mutant strain Y98 may be attributed to the upregulation of BafD and BafE in the type I polyketide structures pathway by 1.18 and 1.20 times, and the downregulation of ndh, nuoA, nuoB, nuoE in the oxidative phosphorylation pathway by 0.62, 0.72, 0.69, and 0.77 times, respectively. This study provides a novel strategy for enhancing Baf A1 production and generates valuable insights for the breeding of other Streptomyces strains.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Fujian Key Laboratory of Screening for Novel Microbial Products, Fujian Institute of Microbiology, 25 Jinbu Road, Fuzhou, 350007, P. R. China.
- The School of Pharmacy, Fujian Medical University, 1 North Xuefu Road, Fuzhou, 350122, P. R. China.
- Fujian Key Laboratory of Screening for Novel Microbial Products, Fujian Institute of Microbiology, 25 Jinbu Road, Fuzhou, 350007, P. R. China. zjian503@163.com.
- The School of Pharmacy, Fujian Medical University, 1 North Xuefu Road, Fuzhou, 350122, P. R. China. zjian503@163.com.
Förderung
- The Key Technology Research on High-Yield Strain Selection and Fermentation Process of V-ATPase Inhibitor Bafilomycin
Zitieren
APA
Sun, F., Yuan, Y., Chen, H., Fang, Z., Shi, Y., Jiang, H., & Zhou, J. (2025). Enhanced bafilomycin A1 production in Streptomyces Griseobrunneus via protoplast fusion combined with high-throughput screening. World Journal of Microbiology and Biotechnology. https://doi.org/10.1007/s11274-025-04602-5
Vancouver
Sun F, Yuan Y, Chen H, Fang Z, Shi Y, Jiang H, et al. Enhanced bafilomycin A1 production in Streptomyces Griseobrunneus via protoplast fusion combined with high-throughput screening. World Journal of Microbiology and Biotechnology. 2025. doi:10.1007/s11274-025-04602-5
BibTeX
@article{Sun2025,
author = {Sun, Fei and Yuan, Yuan and Chen, Haimin and Fang, Zhikai and Shi, Yeshi and Jiang, Hong and Zhou, Jian},
title = {Enhanced bafilomycin A1 production in Streptomyces Griseobrunneus via protoplast fusion combined with high-throughput screening},
journal = {World Journal of Microbiology and Biotechnology},
year = {2025},
doi = {10.1007/s11274-025-04602-5}
}
EUVIMED